MTOR and pulmonary hypertension: We had, therefore, successfully aimed to inhibit this pathway through usage of rapamycin which potently inhibits mTOR [8] to not only prevent but also reverse vascular remodeling processes and right ventricular signs of pulmonary hypertension in mice held under hypoxic conditions.